September 19-21, 2016
Parsippany Hilton

2016 Agenda

Print agenda

Sunday, September 18

8:00pm - 11:00pm
Exhibitor Set Up
6:00pm - 9:00pm
Welcome Reception & Dinner (Dress Business Casual)

Monday, September 19, 2016 - Day 1

9:00am - 11:00am
Buyer CMC, Medicinal Chemistry & Commercial API Manufacturing Invitation Only Private Breakfast (Location TBA)
9:00am - 11:00am
Full Breakfast All Attendees in Exhibit Halls
9:00am - 12:00pm
Exhibitor Set Up
9:00am - 8:00pm
14 Private Meetings Rooms Open For Exhibitors Only (Use online portal to request meeting rooms)
12:00pm - 5:00pm
Exhibit Halls Open
2:30pm - 3:30pm
Afternoon Snacks & Refreshments in Exhibit Halls
6:00pm - 9:00pm
Welcome Reception & Dinner For All Attendees

Tuesday, September 20, 2016 - Day 2

7:00am - 6:00pm
Exhibit Halls Open
7:00am - 8:00pm
14 Private Meeting Rooms Open for Exhibitors Only (Use online portal to set up meetings)
7:30am - 10:00am
Full Breakfast in Exhibitor Halls
8:00am - 10:00am
Buyer Invitation Only Breakfast for Discovery, MedChem, CMC & Commercial API Manufacturing (Location TBA)
9:00am - 3:00pm
Exhibitor Presentations Track C
9:45am - 11:00am
Networking & Snacks in Exhibit Halls
Track A Track B Track C

9:00 - 09:45 Panel Discussion
Sourcing Strategies to Mitigate Supplier Risk
Jay A. Cadieux, Ph.D., PMP
Director, CMC & Intellectual Property
Xenon Pharmaceuticals Inc.
Zhengming (Jimmy) Chen, Ph.D.
Senior Director, Pharmaceutical Sciences
Shionogi Inc
Roger Hanselmann
Director Process Research and Development
Akebia Therapeutics
Evan Hecker, Ph.D.
Director of Process Chemistry
Karyopharm Therapeutics
James Kanter
Director of CMC
Portola Pharmaceuticals
Mark A. Krook, Ph.D.
Senior Director, Portfolio Management
Janssen, A Johnson & Johnson Company
Deborah Minor, Ph.D.
President
Drug Discovery Alliances
Maxwell M. Reeve, Ph.D.
Director Drug Substance Development
Melinta Therapeutics

11:30am - 12:15pm
Networking & Refreshments in Exhibit Halls
12:15pm - 1:45pm
Luncheon in Main Restaurant
Track A Track B Track C

2:00 - 3:00 Panel Discussion
Pharmaceutical Co. Hosted Roundtables for 3 Minute Supplier Speed Meetings
Participants, go to either Exhibit Hall A or B. No presentations, just business cards, and 3 minute chat, then move to next buyer


Intrexon Corporation
API Development

Celgene Corporation Table #3
Technical Affairs

Gilead Sciences
No Suppler Profile Preference
"We Prefer it to be a Spontaneous Event!"

Eleison Pharmaceuticals
Late Stage Anti-Cancer Drug Development
API, DP Mfg., Release and Stability Testing

Eli Lilly & Co.
API Development

Pfizer, Inc. Table #1
CRO/CMO, Development, Intermediates,
APIs and Contract Manufacturing

Blueprint Medicines
Late Discovery Through Clinical Validation
Chemistry, Formulation, Strong Analytical

Novartis
DS, Formulation Development and Manufacture,
including Analytics

Verastem
Drug Substance, API, Development & Manufacturing
of intermediates & cGMP API for oncology drug candidates

Merck Table #2
Process Research & Development

United Therapeutics
Raw Materials/Starting Materials,
Intermediates, Scale-Up, Analytical Method
Development, Polymorph Screening

Melinta Therapeutics
API Development and Raw Materials

Epizyme
API & DP Development; Regulatory Strategies for Phase 1

Genentech
High potent Small Molecule API & DP Clinical GMP manufacture
High potent milling

Amgen, Inc.
TBD

2:00 - 3:00 Panel Discussion
Pharmaceutical Co. Hosted Roundtables for 3 Minute Supplier Speed Meetings
Participants, go to either Exhibit Hall A or B. No presentations, just business cards, and 3 minute chat, then move to next buyer


Takeda Pharmaceuticals
Medicinal Chemistry/Discovery

Sumitomo Dainippon Pharma Co., Ltd.
Medicinal Chemistry-Support Synthesis Services

Pfizer Table #2
Discovery & Medicinal Chemistry

Boehringer-Ingelheim Pharma
Medicinal Chemistry/Discovery

Celgene Corporation Table #1
Medicinal Chemistry/Discovery

Dermira, Inc.
Integrated Discovery-to-Phase I Capability
No Pure-Play API or MedChem

Celgene Corporation Table #2
Early Development

Merck Table #1
Discovery/Medicinal Chemistry

Receptos, Inc.
GMP manufacturers with Process Development Capabilities
Analytical Development Group and Stability Program

AbbVie, Inc.
Large volume GMP production with Containment
Small Volume, Highly Potent GMP production
API Solids Processing
Regulatory Starting Materials

Newron Pharmaceuticals
CRO/CMOs for API, Drug Product, Analytical and
Clinical Supply Chain Management. On API,
Small Molecules and Biologics

Sanofi-Aventis
CRO/CMO; Process R&D ; Intermediates
Everything for early clinical phases up to proof of concept

Tolero Pharmaceuticals
API and drug product CMOs Pre-IND to commercial
phase appropriate development, including solid state API
studies and QbD in support of process validation.

X-Rx Discovery, Inc.
Need CMO to scale up 40-100kg of API. Also need a new
discovery focused CRO for early stage programs

2:00 - 3:00 Panel Discussion
EXHIBITOR SHOWCASE

2:00pm - 3:00pm
Networking & Snacks in Exhibit Halls
Track A Track B Track C

3:00 - 3:30
Development and Piloting of High Potent API Processes
Thomas Cleary, Ph.D.
Principal Site Manager, External Development Collaborations
Genentech

3:45pm - 4:30pm
Networking & Snacks in Exhibit Halls
5:00pm - 9:00pm
Evening Reception & Party

Wednesday, September 21, 2016 - Day 3

7:30am - 6:00pm
Exhibit Halls Open
7:30am - 10:00am
Full Hot & Cold Breakfast in Exhibit Halls
7:00am - 6:00pm
Private Meeting Rooms Open (Use online portal to book)
8:00am – 10:00am
Buyer Invitation Only Breakfast for Discovery, MedChem, CMC & Commercial API Manufacturing (Location TBA)
9:00am - 5:00pm
Exhibitor Presentations Track C
Track A Track B Track C

9:00 - 09:45 Panel Discussion
Establishing Successful Raw Material and Intermediate Supply Chains for API Development
Stuart G. Levy, Ph.D.
Principal
SGL Chemistry Consulting
Dave Lonergan, Ph.D.
Senior Director, Chemistry
PharmAkea Therapeutics
Tim Maher, Ph.D.
Associate Director, Custom API and Intermediate Sourcing
Merck & Co.
Michael Markey, Ph.D.
Principal Scientist, Small Molecule Process Development
Radius Health, Inc.
Sriram Naganathan, Ph.D.
Senior Director, Chemical Development
Dermira, Inc.
Surendra Singh, Ph.D.
Director, CMC
Verastem, Inc.

9:45am – 11:00am
Networking & Snacks in Exhibit Halls
Track A Track B Track C

11:00 - 11:30
Virtual Drug Discovery and Development: Strategies for Successful Projects with Limited Budgets
Daniel Levy, Ph.D.
Principal Consultant
DEL BioPharma

11:45am – 12:30pm
Networking & Snacks in Exhibit Halls
12:30pm - 1:45pm
Luncheon in Main Restaurant
Track A Track B Track C
2:45pm - 3:45pm
Networking & Snacks in Exhibit Halls
Track A Track B Track C
4:30pm
Event Concludes

See you in May 2017!